Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations

EFPIA Newsletter 3 March 2022




Pharmaceutical industry response to the war in Ukraine
10 March 2022

Supporting people affected by the war Read more

EFPIA statement on the Commission response to the European Parliament non-legislative resolution...
02 March 2022

We are committed to the science-based phase-in of methods to replace the use of animals for scientific purposes and... Read more




What do rare cancers and rare diseases have in common? (Guest blog)
28 February 2022 - Ivana Cattaneo

Rare Diseases Day: Now is the time to put rare cancers in all policies, addressing gaps in diagnosis, treatment and... Read more


Rare Disease Day | My Mission Possible is to help make treatments for rare disease less rare


Dirk Vander Mijnsbrugge
Vice President Medical Affairs Pfizer Rare Disease on Gene Therapy Read more

Selena Freisens
M.D. Head Medical Affairs, Global Rare Diseases at Chiesi Read more

Mirella Ezban
Scientific Vice President, Novo Nordisk Read more

Max Wegner
Senior Vice President, Head of Regulatory Affairs, Bayer Read more




The shake-up of orphan and pediatric rules
17 March 2022 (Virtual event)

Organised in partnership with POLITICO Read more

DIA Europe 2022
29 March 2022 (Hybrid conference (virtual - Brussels))

Advancing Health Priorities Read more


What we are reading


Data sharing holds key to progress on rare diseases in Europe
On 28 February 2022 (Financial Times)

Rare diseases are difficult to study as scientists must first find patients, who can only be found if they have been... Read more

The EU’s Industrial Strategy: Blessing or Curse for Knowledge-intensive Industries?
On 01 March 2022 (ECIPE)

If the EU is to remain attractive to internationally competitive knowledge-intensive industries, policymakers need to... Read more